November 16, 2007
The United States Anti-Doping Agency (USADA) announced today that Jeffrey Chakouian, 25, of Normal, Illinois, an athlete in the sport of track and field, tested positive for a prohibited substance and accepted a one-year suspension for his first doping offense.
A sample collected from Chakouian September 5, 2007 as part of the USADA Out-of-Competition Testing Program tested positive for hydrochlorothiazide, which is a prohibited substance in the class of diuretics under the rules of the International Association of Athletics Federations (IAAF) and USADA, both of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency (WADA) Prohibited List.
Chakouian’s one-year period of ineligibility begins September 28, 2007, the date he accepted a provisional suspension. Additionally, Chakouian is disqualified from all competitive results achieved subsequent to September 5, 2007. USA Track & Field, the national governing body for the sport in the United States, will carry out the sanction.
Although hydrochlorothiazide is a prohibited substance under the applicable rules, an athlete who provides documentation in advance of competition, confirming the diagnosis of a valid medical need for hydrochlorothiazide, may receive an exemption allowing the use of the substance. Chakouian’s use of hydrochlorothiazide was under the care of a physician for medical treatment of hypertension (high blood pressure) but without the advance approval required by the rules of sport.
USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement. USADA is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.